Valuation : 10x Genomics, Inc.

Market Cap 7.81B 6.74B 6.35B 5.79B 10.82B 738B 10.9B 75.19B 29.18B 377B 29.35B 28.7B 1,240B P/E 2026 *
-82.3x
P/E 2027 * -85.5x
Enterprise Value 7.33B 6.32B 5.96B 5.43B 10.15B 693B 10.22B 70.53B 27.37B 354B 27.53B 26.93B 1,163B EV / Sales 2026 *
11.8x
EV / Sales 2027 * 10.7x
Free-Float
90.86%
Yield 2026 *
-
Yield 2027 * -
1 day+1.20%
1 week-5.59%
Current month-2.85%
1 month+29.06%
3 months+97.56%
6 months+162.19%
Current year+271.98%
1 week 58.7
Extreme 58.7
65.74
1 month 44.39
Extreme 44.39
66.94
Current year 15.9
Extreme 15.9
66.94
1 year 11.16
Extreme 11.16
66.94
3 years 6.78
Extreme 6.78
66.94
5 years 6.78
Extreme 6.78
191.15
10 years 6.78
Extreme 6.78
208.99
Manager TitleAgeSince
Chief Executive Officer 49 02/07/2012
President 51 01/10/2012
Director of Finance/CFO 51 12/08/2024
Director TitleAgeSince
Director/Board Member 51 02/07/2012
Director/Board Member 49 02/07/2012
Chairman 68 01/08/2013
Date Insider Type Main position Quantity % Market Cap. Importance
26/08/26 Sell

Founder

-10,486 0.0090%
24/08/26 Sell

Chief Financial Officer

-17,166 0.0147%
24/08/26 Sell

Founder

-18,545 0.0159%
Change 5-day change 1-year change 3-year change Capi.($)
+1.32%-5.59%+353.78%+15.61% 7.81B
-3.54%-7.40%+137.98%+348.26% 22.06B
-0.26%+1.75%-34.72%-20.97% 10.34B
-0.50%-8.45%-32.84% - 7B
+0.01%+0.12%+82.56%+52.82% 6.58B
-0.10%-1.48%-18.99%-20.00% 5.93B
+0.71%+0.95%-8.68%-20.73% 4.35B
-1.39%+3.96%+72.05%+84.22% 4.32B
-0.42%-3.57%-20.62%-27.96% 2.81B
-0.51%+1.48%-26.32%-6.59% 1.35B
Average -0.49%-2.28%+50.42%+44.96% 7.26B
Weighted average by Cap. -1.12%-2.14%+80.35%+122.07%

Financials

2026 *2027 *
Net sales 620M 535M 504M 459M 859M 58.61B 865M 5.97B 2.32B 29.96B 2.33B 2.28B 98.43B 680M 587M 553M 503M 941M 64.23B 948M 6.54B 2.54B 32.84B 2.55B 2.5B 108B
Net income -95.77M -82.62M -77.83M -70.91M -133M -9.05B -134M -921M -358M -4.63B -360M -352M -15.19B -89.66M -77.35M -72.86M -66.39M -124M -8.47B -125M -863M -335M -4.33B -337M -329M -14.22B
Net Debt -484M -417M -393M -358M -670M -45.71B -675M -4.66B -1.81B -23.37B -1.82B -1.78B -76.77B -539M -465M -438M -399M -746M -50.94B -752M -5.19B -2.01B -26.04B -2.02B -1.98B -85.56B
Logo 10x Genomics, Inc.
10x Genomics, Inc. is a life science technology company. The Company's integrated solutions include instruments, consumables and software for single cell and spatial biology systems. Its single cell portfolio, powered by Chromium platform, includes its Chromium X Series, Chromium Connect and legacy Chromium Controller instruments, microfluidic chips and related consumables, which enables throughput analysis of individual biological components. Its Visium platform enables researchers to understand the spatial positions of biological analytes within tissues at high resolution. Its Xenium platform for in situ analysis is designed to give scientists the ability to not only locate and type cells in their tissue context. Its products include Chromium Single Cell Gene Expression, Chromium Single Cell Gene Expression Flex, Chromium Single Cell Immune Profiling, Chromium Single Cell assay for transposase accessible chromatin (ATAC), Visium Spatial Gene Expression, and others.
Employees
1,178
Date Price Change Volume
02/09/26 $60.74 +1.27% 880,733
01/09/26 $59.98 -3.96% 1,963,698
31/08/26 $62.45 +1.48% 2,656,719
28/08/26 $61.54 -5.10% 2,361,222
27/08/26 $64.85 +0.92% 2,332,537
Trader
Investor
-
Global
-
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
59.98USD
Average target price
51.00USD
Spread / Average Target
-14.97%

Quarterly revenue - Rate of surprise